The KSM-66 group also demonstrated a 27.9% reduction in serum cortisol levels.
KSM-66 ashwagandha significantly reduces stress and cortisol levels, according to a new study published in the Indian Journal of Psychological Medicine. KSM-66 is an ingredient from supplier Ixoreal Biomed Private Ltd. (Hyderabad, India).
In the 60-day, double-blind, randomized, placebo-controlled trial, 64 subjects with a history of chronic stress were given either a placebo or one capsule containing 300 mg of KSM-66 extract.
During the trial, subjects were evaluated using psychometric measurements, including the Perceived Stress Scale (PSS), the General Health Questionnaire-28 (GHQ-28), and the Depression Anxiety Stress Scale (DASS). The GHQ-28 stress measurement showed a 72.3% reduction in stress from baseline; the DASS showed a 71.6% reduction; and the PSS showed a 44% reduction.
Researchers said that on the whole, the KSM-66 group experienced improved relaxation, mental calmness, sleep, and productivity. The KSM-66 group also demonstrated a 27.9% reduction in serum cortisol levels.
“This study examined how KSM-66 functions as an adaptogen assisting the body in producing a normalizing effects for reducing stress and anxiety,” says Kartikeya Baldwa, director of Ixoreal Biomed.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Synergistic blend of fructooligosaccharide and L-theanine supports memory in recent study
June 10th 2024A recent study found that the combination of fructooligosaccharide (FOS) and L-theanine, marketed as GBL-Memory from Green Bioactives, based in Edinburgh, Scotland was able to support memory in both animals and humans.